Clinical Trial Update: Switching From Xiidra to TRYPTYR [Phase 4]

View source ↗

Summary

Phase 4 trial update indicates a switch from Xiidra to TRYPTYR for dry eye conditions; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Dry Eye Syndrome

Drugs mentioned

• TRYPTYR (ACOLTREMON)
• Xiidra (Lifitegrast)

Snippet

Sponsor: Southern College of Optometry | Conditions: Dry Eye, Dry Eyes Chronic | Phase 4 | Status: NOT_YET_RECRUITING